A review on the strategies for the development and application of new anti-arthritic agents.
Lewis
A J
AJ
Wyeth Ayerst Research, Princeton, New Jersey, USA.
Keft
A F
AF
D000818:Animals; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001168:Arthritis / Q000188:drug therapy* / Q000209:etiology; D002448:Cell Adhesion / Q000187:drug effects; D016207:Cytokines / Q000502:physiology; D006801:Humans; D007167:Immunotherapy; D016859:Lipoxygenase Inhibitors / Q000627:therapeutic use; D008666:Metalloendopeptidases / Q000037:antagonists & inhibitors; D010741:Phospholipases A / Q000037:antagonists & inhibitors; D011448:Prostaglandin Antagonists / Q000627:therapeutic use
D018501:Antirheumatic Agents; D016207:Cytokines; D016859:Lipoxygenase Inhibitors; D011448:Prostaglandin Antagonists; D010741:Phospholipases A; D008666:Metalloendopeptidases